Phase 2b Controlled Study of Dosing Techniques - Part B

Completed · Phase 2

Conditions studied: Dry Eye

In brief

Double-masked, dose-response of two concentrations of IVW-1001

Key facts

Study ID

NCT07161011

Run by

IVIEW Therapeutics Inc.

People needed

15

Starts

2025-09-08

Expected to finish

2025-11-03

Last updated by the study team

2026-03-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Corneal fluorescein staining score of 4 in either eye in any zone using the National Eye Institute grading system at either the Screening Visit or the Baseline Visit
• IOP ≥23 mmHg in either eye at either the Screening Visit or the Baseline Visit
• History of glaucoma or ocular hypertension in either eye requiring past or current medical or surgical intervention

Where it is running

• Eye Research Foundation — Newport Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.